Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006879
Filing Date
2020-05-20
Accepted
2020-05-20 16:46:38
Documents
65
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nrbo-20200331x10q.htm 10-Q 1224171
2 EX-31.1 nrbo-20200331ex311facece.htm EX-31.1 17953
3 EX-32.1 nrbo-20200331ex321c7afd9.htm EX-32.1 12149
  Complete submission text file 0001558370-20-006879.txt   4776326

Data Files

Seq Description Document Type Size
4 EX-101.INS nrbo-20200331.xml EX-101.INS 845760
5 EX-101.SCH nrbo-20200331.xsd EX-101.SCH 43115
6 EX-101.CAL nrbo-20200331_cal.xml EX-101.CAL 39865
7 EX-101.DEF nrbo-20200331_def.xml EX-101.DEF 153544
8 EX-101.LAB nrbo-20200331_lab.xml EX-101.LAB 392385
9 EX-101.PRE nrbo-20200331_pre.xml EX-101.PRE 295307
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37809 | Film No.: 20898711
SIC: 2834 Pharmaceutical Preparations